PIPELINE

Legend of development stages:

Discovery Phase
Preclinical Phase
Clinical Phase I-III

List of programs in the pipeline:

Program: LU2020

Product Type: New drug synergy, Nanoparticle
Main indication: Breast, colorectal, prostate cancers
Development Stage: Preclinical Phase

Program: WRM2023

Product Type: New drug synergy, Nanoparticle
Main indication: Glioblastoma
Development Stage: Preclinical Phase

Program: KR2020

Product Type: New drug synergy, Nanoparticle
Main indication: Lung cancer
Development Stage: Preclinical Phase

Program: MEL2024

Product Type: New drug synergy, Nanoparticle
Main indication: Melanoma
Development Stage: Preclinical Phase

Program: WA2021

Product Type: siRNA
Main indication: Solid tumors with genetic alterations
Development Stage: Preclinical Phase

Program: EL2024

Product Type: siRNA / microRNA
Main indication: Liver cancer
Development Stage: Preclinical Phase